Similar articles

• Pre-clinical models for immunotherapy of melanoma.

  Reisfeld RA. Reisfeld RA. Prog Clin Biol Res. 1989;288:183-93. Prog Clin Biol Res. 1989. PMID: 2654950 Review. No abstract available.
• Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.

  Chen ZJ, Yang H, Liu CC, Mittelman A, Ferrone S. Chen ZJ, et al. Pigment Cell Res. 1992;Suppl 2:113-22. doi: 10.1111/j.1600-0749.1990.tb00360.x. Pigment Cell Res. 1992. PMID: 1409413 Clinical Trial. No abstract available.
• Melanoma localization in nude mice with monoclonal Fab against p97.

  Beaumier PL, Krohn KA, Carrasquillo JA, Eary J, Hellström I, Hellström KE, Nelp WB, Larson SM. Beaumier PL, et al. J Nucl Med. 1985 Oct;26(10):1172-9. J Nucl Med. 1985. PMID: 4045562
• Potential of genetically engineered monoclonal antibodies for cancer immunotherapy.

  Reisfeld RA. Reisfeld RA. Pigment Cell Res. 1992;Suppl 2:109-12. doi: 10.1111/j.1600-0749.1990.tb00359.x. Pigment Cell Res. 1992. PMID: 1409412 Review. No abstract available.
• Human tumor antigens.

  Reisfeld RA, Cheresh DA. Reisfeld RA, et al. Adv Immunol. 1987;40:323-77. doi: 10.1016/s0065-2776(08)60242-4. Adv Immunol. 1987. PMID: 3591561 No abstract available.